Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma included in S&P Global Sustainability Yearbook 2024

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Our Mumbai team title sponsored ‘Cyclothon 2024’, attended by 700+ volunteers to create awareness about environment conservation & support renal ailments’ treatment. Proceedings from the event will be used to donate dialysis machines to hospitals.

#Pedalforacause #WeAreSun


The Sun Pharma Science Foundation hosted a day-long symposium around the theme, ‘Pathogen Discovery & Management of Future Epidemics’. Eminent scientists, scholars, & enthusiastic students came together to engage in thought-provoking discussions igniting innovation & research.

Kirti Ganorkar, our CEO, India Business, takes a trip down memory lane, reflecting on his journey of 25 years with Sun. He shares what sets the Sun culture apart - one where people are truly offered the freedom to innovate and take risks, enabling them to flourish and thrive.

In 2018, we launched our flagship specialty product, ILUMYA™️, a safe and effective treatment for moderate-to-severe plaque psoriasis, in USA. ILUMYA™️ is now making a difference to patients' lives across multiple countries.

#40UnderTheSun #ReachingPeopleTouchingLives #WeAreSun

Presenting our ‘Reshine’ program, designed to provide a welcoming and inclusive environment for women ready to resume their professional journey. Seize this opportunity to relight the flame of your career aspirations.
Apply now, email us at: [email protected]



Our Annual #GlobalHRMeet, CATALYST 2024 saw 100+ HR leaders from over 14 countries come together to chart out the strategy for the next year, over round table discussions, brainstorming sessions & team building activities!

#WeAreSun #SunPharma

In 2016, we introduced Gemcitabine InfuSMART, the first-ever ready-to-administer bag for oncology treatment. Developed in-house by our scientists, this innovation has since benefited numerous patients, making it a significant advancement in cancer care.

#40UnderTheSun #SunPharma

Sun Pharma has been included in the S&P Global Sustainability Yearbook 2024. This recognition underscores our unwavering commitment to embedding Environmental, Social, and Governance (ESG) principles across our diverse business operations.

Read more:

Load More

Find out more


Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.


Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.


We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.


Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue